Lung transplantation: the ideal treatment for diffuse disease?

P. Corris (Newcastle-Upon-Tyne, United Kingdom)

Source: Annual Congress 2006 - Up to date management of bronchiectasis
Session: Up to date management of bronchiectasis
Session type: Symposium
Number: 4783

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Corris (Newcastle-Upon-Tyne, United Kingdom). Lung transplantation: the ideal treatment for diffuse disease?. Annual Congress 2006 - Up to date management of bronchiectasis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Rapid decline in lung disease other than COPD: when should lung transplantation be considered?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007


Selection of emphysema patients for lung transplantation today
Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria?
Year: 2004

Lung transplantation (LTx) for fibrotic diseases: a single centre experience
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005

Paediatric lung transplantation
Source: Eur Respir J 2004; 24 : 839-845
Year: 2004



Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Paediatric lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=243
Year: 2003

Lung transplantation for diffuse bronchiectasis
Source: Annual Congress 2012 - Update on bronchiectasis
Year: 2012


The burden of sinus disease in CF candidates for lung transplantation
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012



Panel discussion: COVID-19 and lung transplantation: how to handle?
Source: ERS webinar 2022

Access for REGISTERED non-members

Year: 2022

Idiopathic pulmonaryfibrosis: the native lung after single lung transplantation
Source: Eur Respir J 2003; 22: Suppl. 45, 328s
Year: 2003

Outcomes of lung transplantation for bronchiectasis
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Is lung transplantation still indicated?
Source: Annual Congress 2006 - Contemporary management of patients with end-stage emphysema
Year: 2006


Lung transplantation in silicosis, still rare
Source: Virtual Congress 2020 – Occupational lung diseases
Year: 2020


CF sinus disease after lung transplantation
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016

Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003